lapatinib news
Your Search Returned 43 tagged news reports
Eddingpharm to acquire Tykerb rights from GlaxoSmithKline China
London :: United Kingdom | 1 month ago
Credibility
Tykerb in combination with capecitabine is indicated to treat advanced or metastatic breast cancer patients whose tumors overexpress HER2 and who were previously treated with anthracycline, a taxane and trastuzumab. Eddingpharm chairman and chief
Tags:
Breast Cancer Drug Spares Life
New York City :: NY :: USA | 1 month ago
Credibility
Published April 07, 2013 FoxNews.com Fifty-year-old Lisa Canale has been battling breast cancer for 15 years and although she lives with the diagnosis daily, she said she feels great. It's partly due to a new drug she's been taking called Kadcyla,
Tags:
New breast cancer drug prolongs life
New York City :: NY :: USA | 1 month ago
Credibility
Published April 07, 2013 FoxNews.com Fifty-year-old Lisa Canale has been battling breast cancer for 15 years and although she lives with the diagnosis daily, she said she feels great. It's partly due to a new drug she's been taking called Kadcyla,
Tags:
F.D.A. Approves Breast Cancer Drug
Waltham :: MA :: USA | 3 months ago
Credibility
February 22, 2013 The Food and Drug Administration on Friday approved a new type of drug that combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side
Tags:
Wall Street Loves Galena Biopharma. Should You?
New York City :: NY :: USA | 6 months ago
Credibility
But just because Wall Street loves it doesn't mean you have to. Analyst sentiment is only just the jumping-off place for your own research...This is key to Galena's NeuVax therapy because Herceptin validates the HER2 receptor -- a protein that turns
Tags:
New way to carry chemotherapy improves survival
Toronto :: Canada | 7 months ago
Credibility
Story T-DM1 (trastuzumab emtansine) is made up of the antibody trastuzumab and the chemotherapy DM1 attached together using a stable linker molecule, and allows chemotherapy to be carried with the targeted therapy, trastuzumab, right to breast cancer
Tags:
Anti-HIV Drug Could Be Repurposed To Fight Aggressive Breast Cancer
New York City :: NY :: USA | 8 months ago
Credibility
Wikimedia Commons) Johns Hopkins School of Medicine researchers found that the drug nelfinavir successfully inhibited the growth of HER2-positive breast cancer cells both in the lab and in mice. They published their results on Friday in the Journal
Tags:
New Data from Phase III EMILIA Study Showed Genentech's Trastuzumab Emtansine (T-DM1) Significantly Improved Survival of People With HER2-Positive Metastatic Breast Cancer
South San Francisco :: CA :: USA | 9 months ago
Credibility
significantly extended the lives (improved overall survival) of people with HER2-positive metastatic breast cancer (mBC) compared to the combination of lapatinib and Xeloda® (capecitabine). HER2-positive mBC who had previously received Herceptin® (
Tags:
GSK pulls U.S. bid to use Tykerb with Herceptin
London :: United Kingdom | 10 months ago
Credibility
Topics Signage is pictured on the company headquarters of GlaxoSmithKline in west London July 21, 2008. GlaxoSmithKline announce their half yearly results on Wednesday July 23. British group GlaxoSmithKline has pulled a U.S. application seeking
Tags:
Gateway to begin phase II cancer study
London :: United Kingdom | 11 months ago
Credibility
Led by Edward Lin,a medical oncologist at the University of Washington and his collaborators, the study will be the first to specifically target colon cancer stem cells. The study will apply a combination drug therapy of Capecitabine (a chemotherapy
Tags:
